Assays for myasthenia gravis
US5041389A · kind A · utility
5Cited by
2References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 29, 1990 |
| Grant date | Aug 20, 1991 |
| Priority date | — |
| Expiry date | May 29, 2010 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/804
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Improved asssays are provided for anti-acetylcholine receptor protein autoantibodies in the sera of patients with myasthenia gravis. The basis for the improved assays is the discovery that large quantities of acetylcholine receptor protein, that, for practical purposes in immunoassays, is immunologically indistinguishable from human muscle acetylcholine receptor protein, can be isolated from cells of the human medullablastoma-derived cell line TE671.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.